A TEM protocol for quality assurance of in vitro cellular barrier models and its application to the assessment of nanoparticle transport mechanisms across barriers.

We report here a protocol to characterise and monitor the quality of in vitro human cellular barrier models using Transmission Electron Microscopy (TEM), which can be applied for transport assays, mechanistic studies and screening of drug/compound (including nanoparticle) penetration across such biological barriers. Data from two examples of biological barriers are given, namely the hCMEC/D3 endothelial blood-brain barrier model, and the Caco-2 intestinal epithelial barrier model, to show the general applicability of the method. Several aspects of this method are applicable to the quality assurance of in vitro barrier models, e.g., assessment of the multi or mono-layer structure of the endothelial cells; identification of any potential "holes" in the barrier that could confound transport assay results; validation of tight junction expression; and determination of the types and amounts of key cellular organelles present in the barrier to account for any significant changes in phenotype that may occur compared to the in vivo situation. The method described here provides a key advantage in that it prevents loss of the filter membrane during monolayer sectioning, thereby preserving critical details associated with the basal cell membrane. Applicability of the protocol for other in vitro biological barriers, such as the blood-foetus, blood-testes, blood-cerebrospinal fluid (CSF) and lung alveolar-capillary barriers is also discussed. Additionally, we demonstrate the use of the method for assessment of nanoparticle transport across cellular barriers and elucidation of transcytosis mechanisms. Sequential events of cellular endocytosis, localisation and transcytosis can be described in detail by TEM imaging, revealing useful sub-cellular details that provide evidence for the mechanism of nanoparticle transport in the hCMEC/D3 blood-brain barrier model and the Caco-2 intestinal epithelial cell model. Potential artefacts resulting from the nanoparticles interacting with the Transwell membranes can also be assessed.

[1]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[2]  K. Dawson,et al.  Time and space resolved uptake study of silica nanoparticles by human cells. , 2011, Molecular bioSystems.

[3]  Lutz Edler,et al.  Biostatistical Methods for the Validation of Alternative Methods for In Vitro Toxicity Testing , 2003, Alternatives to laboratory animals : ATLA.

[4]  T. Imai,et al.  Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. , 1997, Journal of pharmaceutical sciences.

[5]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[6]  M. Coelho,et al.  Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies. , 2014, Nanomedicine.

[7]  Valérie Zuang,et al.  Alternative (non-animal) methods for chemicals testing: Current status and future prospects - Overview , 2002 .

[8]  Sean Callanan,et al.  Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  R. Crooks,et al.  PREPARATION AND CHARACTERIZATION OF 1?2 NM DENDRIMER-ENCAPSULATED GOLD NANOPARTICLES HAVING VERY NARROW SIZE DISTRIBUTIONS , 2004 .

[10]  Delyan R. Hristov,et al.  Stabilising fluorescent silica nanoparticles against dissolution effects for biological studies. , 2012, Chemical communications.

[11]  K. Landfester,et al.  Criteria impacting the cellular uptake of nanoparticles: a study emphasizing polymer type and surfactant effects. , 2011, Acta biomaterialia.

[12]  H. Santos,et al.  The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems. , 2012, Biomaterials.

[13]  David J Brayden,et al.  Growth and characterisation of a cell culture model of the feline blood-brain barrier. , 2006, Veterinary immunology and immunopathology.

[14]  P. Artursson,et al.  Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers , 2007, Nature Protocols.

[15]  A. Keshavarzian,et al.  Intestinal barrier: An interface between health and disease , 2003, Journal of gastroenterology and hepatology.

[16]  Kevin Barraclough,et al.  I and i , 2001, BMJ : British Medical Journal.

[17]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[18]  Horst Spielmann,et al.  A Critical Evaluation of the 2011 ECHA Reports on Compliance with the REACH and CLP Regulations and on the Use of Alternatives to Testing on Animals for Compliance with the REACH Regulation , 2011, Alternatives to laboratory animals : ATLA.

[19]  L. Sibley,et al.  Migration of Toxoplasma gondii across biological barriers. , 2003, Trends in microbiology.

[20]  P. Boor,et al.  Albumin is recycled from the primary urine by tubular transcytosis. , 2013, Journal of the American Society of Nephrology : JASN.

[21]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[22]  Anna Forsby,et al.  Blood-Brain Barrier In Vitro Models and Their Application in Toxicology: The Report and Recommendations of ECVAM Workshop 491,2 , 2004, Alternatives to laboratory animals : ATLA.

[23]  J. Krüssel,et al.  Selection of the In Vitro Culture Media Influences mRNA Expression of Hedgehog Genes, Il-6, and Important Genes regarding Reactive Oxygen Species in Single Murine Preimplantation Embryos , 2012, TheScientificWorldJournal.

[24]  W. Marsden.  I and J , 2012 .

[25]  C. Grobstein,et al.  Morphogenetic Interaction between Embryonic Mouse Tissues separated by a Membrane Filter , 1953, Nature.

[26]  N. Simionescu,et al.  Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis , 1986, The Journal of cell biology.

[27]  Gerrit Borchard,et al.  The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro , 1996 .

[28]  Iseult Lynch,et al.  Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. , 2011, Nanomedicine.

[29]  P. Artursson,et al.  A new diffusion chamber system for the determination of drug permeability coefficients across the human intestinal epithelium that are independent of the unstirred water layer. , 1992, Biochimica et biophysica acta.

[30]  Vesa-Pekka Lehto,et al.  Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. , 2010, ACS nano.

[31]  Kenneth A. Dawson,et al.  Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. , 2012, ACS nano.

[32]  Simon C Watkins,et al.  Caveolae-Dependent and -Independent Uptake of Albumin in Cultured Rodent Pulmonary Endothelial Cells , 2013, PloS one.

[33]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[34]  Michelle Nic Raghnaill,et al.  Paracrine signalling of inflammatory cytokines from an in vitro blood brain barrier model upon exposure to polymeric nanoparticles. , 2014, The Analyst.

[35]  S. Krähenbühl,et al.  The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies , 2008, Journal of neurochemistry.

[36]  M. Bayindir,et al.  Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption. , 2013, Journal of materials chemistry. B.

[37]  H. Davies,et al.  Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123 , 2009, Brain Research.

[38]  Vesa-Pekka Lehto,et al.  Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[39]  L. Dai,et al.  Preparation of cells for assessing ultrastructural localization of nanoparticles with transmission electron microscopy , 2010, Nature Protocols.

[40]  H. Santos,et al.  Cellular interactions of surface modified nanoporous silicon particles. , 2012, Nanoscale.

[41]  Kenneth A Dawson,et al.  Nanoparticle accumulation and transcytosis in brain endothelial cell layers. , 2013, Nanoscale.

[42]  K. Dawson,et al.  Imaging approach to mechanistic study of nanoparticle interactions with the blood-brain barrier. , 2014, ACS nano.

[43]  Yvonne J. Yamanaka,et al.  Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Hamid Soltanian-Zadeh,et al.  Correlation of VEGF and Angiopoietin Expression with Disruption of Blood–Brain Barrier and Angiogenesis after Focal Cerebral Ischemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  K. Dawson,et al.  Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[46]  P. Couraud,et al.  Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier , 2008, The Journal of physiology.

[47]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[49]  H. Santos,et al.  Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. , 2011, Biomaterials.